
MS: Polpharma joins forces with Sandoz
Natalizumab, which is currently being marketed by Biogen, is a humanized monoclonal antibody against the cell adhesion molecule α4-integrin. It is a...

Sanofi buys Synthorx Inc for US$2.35bn
Sanofi SA‘s and Synthorx Inc's Boards approved the deal which forsees that Sanofi will acquire all of the outstanding shares of Synthorx for $68 per...

Lundback swallows migraine drug maker Alder
Alder's first-in-class monoclonal antibody for migraine prevention, eptinezumab, targets the calcitonin gene-related peptide and faces FDA...

Meatable NV raises US$10m in seed funding
BlueYard Capital, the Eurostars Programme of the European Commission, and angel VCs Taavet Hinrikus and Albert Wenger (Union Square Ventures)...

Pierre Fabre amends license agreement with Puma Biotechnology
According the extended agreement, Pierre Fabre may not only market the breast cancer recurrence blocker Nerlynx® (neratinib) within Europe and...

2nd ECP Summer Summit at Henkel HQ, Düsseldorf
On September 26, international representatives from startups, SMEs, large companies. clusters, industry parks and further services providers came...

DPP3 triggers myocardial depression
Results of two independent studies published fast-track and presented on Saturday at ESC Congress 2019 (Paris) by Prof. Alexandre Mebazza...